Post by Linda51 on Jun 17, 2011 10:51:19 GMT -6
Title: FENZIAN ¨C A non-invasive treatment for pain, movement impairments and non- responsive conditions.
Description: Technology that combines gentle, biofeedback and neuromuscular electric stimulation to treat your condition for the quickest healing.
Suzy Powers, Physical Therapist and owner of Powers Physical Therapy on Bainbridge Island and part of the team at Seattle¡¯s Peak Sports and Spine Physical Therapy, was trained and certified in the Fenzian Treatment System by James Colthurst, MD in 2004.
Suzy has had success with Fenzian for a wide variety of conditions including acute and chronic pain, injuries, asthma, neuropathies, scar tissue reduction, edema, peripheral vascular disease, lymphedema, Bells Palsy, fibromyalgia and reduction of many side effects caused by chemotherapy. She has a 24 year history as a PT, working with recreational to professional and Olympic athletes, chronic pain, disease, cancer and illness conditions.
Dr. James Colthurst, the originator of Fenzian, has developed and researched Fenzian to produce an alternative, holistic treatment for main stream medicine to utilize. Along with his clinical work in his hometown in England, James has been immersed in conducting and completing scientific research studies to prove the effectiveness of Fenzian with such prestigious centers as Johns Hopkins, Duke and UCLA School of Medicine. He has shown important success in Wound healing, scar tissue reduction and Asthma improvement to demonstrate the Fenzian¡¯s effectiveness on our body¡¯s internal organs and systems.
How Fenzian works: ¡°Skin and nerve tissue both arise from the embryonic neuroectoderm. Disturbances in the neurological ¡®maintenance network¡¯ may be reflected in altered skin electrical response. The handheld Fenzian Treatment System is designed to find and use alterations in skin
response to its microcurrent signals to encourage the normal physiological pathways to be
re-instated,¡± explains James Colthurst on his web site, www.fenzian.com.
In this lecture, Suzy will present her treatment approach and explanation of how Fenzian works along with individual outcomes for various conditions.
Topic title: Minimally Invasive Surgery for Spinal Cord Tumors
Trent L. Tredway, M.D.
Dr. Tredway is a neurosurgeon specializing in spinal neurosurgery. He has special expertise in minimally invasive techniques and has published several articles on these recently developed techniques. After completing his residency in neurosurgery, he did a fellowship in spinal neurosurgery at the University of Chicago . At the UW, he has faculty appointments in the Department of Neurological Surgery and the Department of Orthopedics and Sports Medicine.
Among his clinical interests are complex spinal surgery, spinal cord tumors, and spinal cord injuries. His patient care philosophy is based on working with patients to develop a treatment plan after the specific medical problem is identified.
Patient Care Philosophy
It is important to derive a treatment plan based on clinical acumen and sound judgment with active patient input. With this philosophy, the patient and physician can choose the best course of treatment for the specific medical problem.
Personal Interests
Mountain biking, snowboarding, fishing
Clinical Interests
All aspects of spinal neurosurgery with special expertise in minimally invasive techniques
Complex spinal surgery
Spinal cord tumors and injuries
Expertise
Neurosurgery, Neurosurgery (Spine)
Topic title: Informal discussion with the audience regarding the emotional aspects of illness.
Lynn Buell, LICSW
Licensed Social Worker (Washington)
Ms. Buell attended the Columbia University School of Social Work in New York and received her Masters in Science in Social Work. She did her field placement in community psychiatry at St. Luke’s Hospital and family therapy at the Adolescent Health Center, Mount Sinai Medical Center. In 1987 she returned to the Pacific Northwest and worked with mental health agencies for seven years providing adult, family, individual and child therapy. She then opened her own private psychotherapy practice and has been providing psychotherapy in her practice for the last 22 years.
Ms. Buell has worked extensively with adults, children and adolescents, having volunteered at Ryther Child Center, completed a summary intensive at the Anna Freud Centre in London. She has also completed a two-year psychodynamic, psychotherapy program at the Seattle Psychoanalytic Society Institute and a one-year child program. In 1996 she entered the CORE program in psychoanalysis at Seattle Psychoanalytic Society & Institute. The didactic part of the program was five years in duration with additional clinical requirements. She graduated from the program in 2002 and in 2006 was certified as a psychoanalyst by the American Psychoanalytic Association. She is currently on faculty on the Seattle Psychoanalytic Society & Institute and COR Northwest Family Development Center. She is also a member of the Northwestern Psychoanalytic Society and teaches at all three schools and societies.
Ms. Buell is a co-chair of a discussion group on psychoanalysis and opera at the American Psychoanalytic Association and is also the chair of the local discussion group entitled Opera on the Couch.
Topic title: Role of stem cell therapy for restoring function and reducing pain after tumors of the spinal cord.
Wise Young, M.D., Ph.D., Professor II
Richard H. Shindell Chair in Neuroscience
Founding Director, W.M. Keck Center for Collaborative Neuroscience
Rutgers, The State University of New Jersey
Distinguished Visiting Professor, The University of Hong Kong
Dr. Wise Young, founding director of the W.M. Keck Center for Collaborative Neuroscience and a professor at Rutgers, The State University of New Jersey, is recognized as one of the world's outstanding neuroscientists. He obtained a bachelor of arts degree from Reed College, a doctorate from the University of Iowa and a medical degree from Stanford University. After a surgery internship at New York University and Bellevue Medical Center, he joined the neurosurgery department at NYU. In 1984, he became director of neurosurgery research. In 1997, as part of Rutgers' commitment to the future, Dr. Young was recruited to establish and direct a world-class center for collaborative neuroscience.
Dr. Young led the team that discovered and established high-dose methylprednisolone (MP) as the first effective therapy for spinal cord injuries. This 1990 work upended concepts that spinal cord injuries were permanent, refocused research, and opened new vistas of hope. This team also played a major role in Dr. Andrew Blight's signal work on 4-aminopyridine (4-AP), which shows significant promise for increasing nerve conductivity.
Dr. Young developed the first standardized rat spinal cord injury model used worldwide for testing therapies, formed the first consortium funded by the National Institutes of Health (NIH) to test promising therapies, and helped establish several widely accepted clinical outcome measures in spinal cord injury research.
Dr. Young founded and served as editor-in-chief of the Journal of Neurotrauma. He organized the National and International Neurotrauma Societies as forums for scientists to share discoveries and collaborate on spinal cord injury and brain research. He serves or has served on advisory committees for the NIH, the National Academy of Sciences, and NICHD, and has served on advisory boards for many spinal cord injury organizations.
Well-known as a leader in spinal cord injury research, Dr. Young is in high demand as a speaker at scientific conferences throughout the world and when media are in need of expert knowledge. He has appeared on ¡®20/20¡¯ with Barbara Walters and Christopher Reeve, ¡®Today¡¯, with Katie Couric, ¡®48 Hours,¡¯ ¡®Eye-to-Eye,¡¯ Fox News, and CNN with Jeff Greenfield. His work has been featured in a Life magazine special edition, USA Today, and innumerable national and international news, talk, and print publications. A few of his many honors include: NIH Jacob Javits Neuroscience Award (1985-1992), Wakeman Award (1991), Tall Texan of the Year Award (1997), "Cure" Award (1998), Trustees Award for Excellence in Research (2001), Asian American Achievement Award (2002), Douglass Medal for work with the advancement of young women in the sciences (2003), and Elizabeth M. Boggs Award for service to the disability community (2004). In August 2001, TIME Magazine named Dr. Young as ¡®America¡¯s Best¡¯ in the field of spinal cord injury research. In 2005 he was the first researcher elected to the Spinal Cord Injury Hall of Fame. In 2006, Dr. Young received The Hope Award ¨C A Salute to Research Innovation, the New Jersey Educator of the Year Award, and the Caring Heart Award. Also in 2006, the Richard H. Shindell Chair in Neuroscience was established at Rutgers University and Dr. Young was named as the first person to hold that chair. In 2007 the Motolinsky Foundation named Wise Young as the recipient of their Distinguished Citizen Award. In 2011 he was selected as the McGowen Distinguished Lecturer.
Dr. Young is committed to bringing treatments to people with chronic spinal cord Injuries. He has built and trained a twenty-five center clinical trial network in China, Taiwan, and Hong Kong where human clinical trials are now underway. He is in the process of establishing clinical trial networks in the United States, Norway, and India with additional countries eager to participate.
Topic title: What to do with the new tumor diagnosis
George Jallo, a native of New Jersey received his medical degree from the University of Virginia and completed his residency in neurosurgery at NYU Medical Center and his fellowship in pediatric neurosurgery at Beth Israel Medical Center in New York before coming to Johns Hopkins in July 2003.
An expert on the use of minimally invasive technologies such as endoscopes, Jallo focuses on the treatment of intradural spinal tumors, brainstem and other brain tumors in both children and adults. He also has extensive clinical experience in intraoperative neurophysiological monitoring and is recognized for his contributions to the treatment of epilepsy, and craniofacial defects. His research interests include novel models of brainstem and spinal cord tumors and local delivery of chemotherapy agents.
Married to Michelle, he spends off-duty hours hiking, bicycling and learning a new hobby: fly fishing.
Topic title: Understanding your Insurance
Donna Bly has called Portland Oregon home for the past 30 years. She graduated from the University of Oregon with a bachelor’s degree in Health Education. She went on to receive her nursing degree (RN) from Pima College in Tucson, Arizona. She has eight years experience working as a staff nurse and over 20 years experience working as a medical coder. She then went on to start her own business as a medical billing advocate after taking courses and becoming a member of the Medical Billing Advocates of America
.
Her expertise ranges from negotiating reductions in medical bills for clients to assisting clients in understanding their medical bills and insurance. She has done hospital bill audits for attorneys and cost analysis for insurance companies. She is especially delighted when she can negotiate bill reductions for the uninsured.
Description: Technology that combines gentle, biofeedback and neuromuscular electric stimulation to treat your condition for the quickest healing.
Suzy Powers, Physical Therapist and owner of Powers Physical Therapy on Bainbridge Island and part of the team at Seattle¡¯s Peak Sports and Spine Physical Therapy, was trained and certified in the Fenzian Treatment System by James Colthurst, MD in 2004.
Suzy has had success with Fenzian for a wide variety of conditions including acute and chronic pain, injuries, asthma, neuropathies, scar tissue reduction, edema, peripheral vascular disease, lymphedema, Bells Palsy, fibromyalgia and reduction of many side effects caused by chemotherapy. She has a 24 year history as a PT, working with recreational to professional and Olympic athletes, chronic pain, disease, cancer and illness conditions.
Dr. James Colthurst, the originator of Fenzian, has developed and researched Fenzian to produce an alternative, holistic treatment for main stream medicine to utilize. Along with his clinical work in his hometown in England, James has been immersed in conducting and completing scientific research studies to prove the effectiveness of Fenzian with such prestigious centers as Johns Hopkins, Duke and UCLA School of Medicine. He has shown important success in Wound healing, scar tissue reduction and Asthma improvement to demonstrate the Fenzian¡¯s effectiveness on our body¡¯s internal organs and systems.
How Fenzian works: ¡°Skin and nerve tissue both arise from the embryonic neuroectoderm. Disturbances in the neurological ¡®maintenance network¡¯ may be reflected in altered skin electrical response. The handheld Fenzian Treatment System is designed to find and use alterations in skin
response to its microcurrent signals to encourage the normal physiological pathways to be
re-instated,¡± explains James Colthurst on his web site, www.fenzian.com.
In this lecture, Suzy will present her treatment approach and explanation of how Fenzian works along with individual outcomes for various conditions.
Topic title: Minimally Invasive Surgery for Spinal Cord Tumors
Trent L. Tredway, M.D.
Dr. Tredway is a neurosurgeon specializing in spinal neurosurgery. He has special expertise in minimally invasive techniques and has published several articles on these recently developed techniques. After completing his residency in neurosurgery, he did a fellowship in spinal neurosurgery at the University of Chicago . At the UW, he has faculty appointments in the Department of Neurological Surgery and the Department of Orthopedics and Sports Medicine.
Among his clinical interests are complex spinal surgery, spinal cord tumors, and spinal cord injuries. His patient care philosophy is based on working with patients to develop a treatment plan after the specific medical problem is identified.
Patient Care Philosophy
It is important to derive a treatment plan based on clinical acumen and sound judgment with active patient input. With this philosophy, the patient and physician can choose the best course of treatment for the specific medical problem.
Personal Interests
Mountain biking, snowboarding, fishing
Clinical Interests
All aspects of spinal neurosurgery with special expertise in minimally invasive techniques
Complex spinal surgery
Spinal cord tumors and injuries
Expertise
Neurosurgery, Neurosurgery (Spine)
Topic title: Informal discussion with the audience regarding the emotional aspects of illness.
Lynn Buell, LICSW
Licensed Social Worker (Washington)
Ms. Buell attended the Columbia University School of Social Work in New York and received her Masters in Science in Social Work. She did her field placement in community psychiatry at St. Luke’s Hospital and family therapy at the Adolescent Health Center, Mount Sinai Medical Center. In 1987 she returned to the Pacific Northwest and worked with mental health agencies for seven years providing adult, family, individual and child therapy. She then opened her own private psychotherapy practice and has been providing psychotherapy in her practice for the last 22 years.
Ms. Buell has worked extensively with adults, children and adolescents, having volunteered at Ryther Child Center, completed a summary intensive at the Anna Freud Centre in London. She has also completed a two-year psychodynamic, psychotherapy program at the Seattle Psychoanalytic Society Institute and a one-year child program. In 1996 she entered the CORE program in psychoanalysis at Seattle Psychoanalytic Society & Institute. The didactic part of the program was five years in duration with additional clinical requirements. She graduated from the program in 2002 and in 2006 was certified as a psychoanalyst by the American Psychoanalytic Association. She is currently on faculty on the Seattle Psychoanalytic Society & Institute and COR Northwest Family Development Center. She is also a member of the Northwestern Psychoanalytic Society and teaches at all three schools and societies.
Ms. Buell is a co-chair of a discussion group on psychoanalysis and opera at the American Psychoanalytic Association and is also the chair of the local discussion group entitled Opera on the Couch.
Topic title: Role of stem cell therapy for restoring function and reducing pain after tumors of the spinal cord.
Wise Young, M.D., Ph.D., Professor II
Richard H. Shindell Chair in Neuroscience
Founding Director, W.M. Keck Center for Collaborative Neuroscience
Rutgers, The State University of New Jersey
Distinguished Visiting Professor, The University of Hong Kong
Dr. Wise Young, founding director of the W.M. Keck Center for Collaborative Neuroscience and a professor at Rutgers, The State University of New Jersey, is recognized as one of the world's outstanding neuroscientists. He obtained a bachelor of arts degree from Reed College, a doctorate from the University of Iowa and a medical degree from Stanford University. After a surgery internship at New York University and Bellevue Medical Center, he joined the neurosurgery department at NYU. In 1984, he became director of neurosurgery research. In 1997, as part of Rutgers' commitment to the future, Dr. Young was recruited to establish and direct a world-class center for collaborative neuroscience.
Dr. Young led the team that discovered and established high-dose methylprednisolone (MP) as the first effective therapy for spinal cord injuries. This 1990 work upended concepts that spinal cord injuries were permanent, refocused research, and opened new vistas of hope. This team also played a major role in Dr. Andrew Blight's signal work on 4-aminopyridine (4-AP), which shows significant promise for increasing nerve conductivity.
Dr. Young developed the first standardized rat spinal cord injury model used worldwide for testing therapies, formed the first consortium funded by the National Institutes of Health (NIH) to test promising therapies, and helped establish several widely accepted clinical outcome measures in spinal cord injury research.
Dr. Young founded and served as editor-in-chief of the Journal of Neurotrauma. He organized the National and International Neurotrauma Societies as forums for scientists to share discoveries and collaborate on spinal cord injury and brain research. He serves or has served on advisory committees for the NIH, the National Academy of Sciences, and NICHD, and has served on advisory boards for many spinal cord injury organizations.
Well-known as a leader in spinal cord injury research, Dr. Young is in high demand as a speaker at scientific conferences throughout the world and when media are in need of expert knowledge. He has appeared on ¡®20/20¡¯ with Barbara Walters and Christopher Reeve, ¡®Today¡¯, with Katie Couric, ¡®48 Hours,¡¯ ¡®Eye-to-Eye,¡¯ Fox News, and CNN with Jeff Greenfield. His work has been featured in a Life magazine special edition, USA Today, and innumerable national and international news, talk, and print publications. A few of his many honors include: NIH Jacob Javits Neuroscience Award (1985-1992), Wakeman Award (1991), Tall Texan of the Year Award (1997), "Cure" Award (1998), Trustees Award for Excellence in Research (2001), Asian American Achievement Award (2002), Douglass Medal for work with the advancement of young women in the sciences (2003), and Elizabeth M. Boggs Award for service to the disability community (2004). In August 2001, TIME Magazine named Dr. Young as ¡®America¡¯s Best¡¯ in the field of spinal cord injury research. In 2005 he was the first researcher elected to the Spinal Cord Injury Hall of Fame. In 2006, Dr. Young received The Hope Award ¨C A Salute to Research Innovation, the New Jersey Educator of the Year Award, and the Caring Heart Award. Also in 2006, the Richard H. Shindell Chair in Neuroscience was established at Rutgers University and Dr. Young was named as the first person to hold that chair. In 2007 the Motolinsky Foundation named Wise Young as the recipient of their Distinguished Citizen Award. In 2011 he was selected as the McGowen Distinguished Lecturer.
Dr. Young is committed to bringing treatments to people with chronic spinal cord Injuries. He has built and trained a twenty-five center clinical trial network in China, Taiwan, and Hong Kong where human clinical trials are now underway. He is in the process of establishing clinical trial networks in the United States, Norway, and India with additional countries eager to participate.
Topic title: What to do with the new tumor diagnosis
George Jallo, a native of New Jersey received his medical degree from the University of Virginia and completed his residency in neurosurgery at NYU Medical Center and his fellowship in pediatric neurosurgery at Beth Israel Medical Center in New York before coming to Johns Hopkins in July 2003.
An expert on the use of minimally invasive technologies such as endoscopes, Jallo focuses on the treatment of intradural spinal tumors, brainstem and other brain tumors in both children and adults. He also has extensive clinical experience in intraoperative neurophysiological monitoring and is recognized for his contributions to the treatment of epilepsy, and craniofacial defects. His research interests include novel models of brainstem and spinal cord tumors and local delivery of chemotherapy agents.
Married to Michelle, he spends off-duty hours hiking, bicycling and learning a new hobby: fly fishing.
Topic title: Understanding your Insurance
Donna Bly has called Portland Oregon home for the past 30 years. She graduated from the University of Oregon with a bachelor’s degree in Health Education. She went on to receive her nursing degree (RN) from Pima College in Tucson, Arizona. She has eight years experience working as a staff nurse and over 20 years experience working as a medical coder. She then went on to start her own business as a medical billing advocate after taking courses and becoming a member of the Medical Billing Advocates of America
.
Her expertise ranges from negotiating reductions in medical bills for clients to assisting clients in understanding their medical bills and insurance. She has done hospital bill audits for attorneys and cost analysis for insurance companies. She is especially delighted when she can negotiate bill reductions for the uninsured.
